ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CHRT Cohort Plc

1,075.00
-65.00 (-5.70%)
07 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cohort Plc LSE:CHRT London Ordinary Share GB00B0YD2B94 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -65.00 -5.70% 1,075.00 181,888 16:35:29
Bid Price Offer Price High Price Low Price Open Price
1,055.00 1,085.00 1,150.00 1,055.00 1,140.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Consulting Svcs,nec 202.53M 15.32M 0.3289 32.08 530.91M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:29 O 3 1,090.00 GBX

Cohort (CHRT) Latest News

Cohort (CHRT) Discussions and Chat

Cohort Forums and Chat

Date Time Title Posts
06/2/202514:12Cohort - Right place at the right Time737
10/4/201811:14Charts-
24/6/201318:14ADVFN Charts: Suggestions for Improvements.13
28/3/200614:31Chart Help Needed16

Add a New Thread

Cohort (CHRT) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Cohort (CHRT) Top Chat Posts

Top Posts
Posted at 09/2/2025 08:20 by Cohort Daily Update
Cohort Plc is listed in the Business Consulting Svcs,nec sector of the London Stock Exchange with ticker CHRT. The last closing price for Cohort was 1,140p.
Cohort currently has 46,571,003 shares in issue. The market capitalisation of Cohort is £491,324,082.
Cohort has a price to earnings ratio (PE ratio) of 32.08.
This morning CHRT shares opened at 1,140p
Posted at 05/2/2025 20:48 by wad collector
Looks like the ticket price might just have risen!
Posted at 24/1/2025 15:24 by mello2024
Just to let shareholders and prospective investors know that CHRT will be presenting on the MelloMonday webinar starting at 4.30pm on the 27th January, 2025.

The programme for the evening is as follows:

4.30pm Interview with Fund Manager, Katen Patel
5:00pm Company presentation from Helios Underwriting plc
5:40pm Company presentation from Solvonis Therapeutics (formerly Graft Polymer)
6.20pm Educational session
6:35pm Company presentation from Cohort plc
7:05pm BASH (Buy, Avoid, Sell Hold) Panel featuring Kevin Taylor and Mark Simpson

Tickets are still available and if you would like one at half price then enter the code MMTADVFN50.
Posted at 20/1/2025 08:53 by estienne
Cohort is a collection of specialist defence companies on whom the likes of BAe and Thales rely in order to integrate their systems and meet performance requirements. QinetiQ is different because its main role in the UK is the Long Term Partner agreement with MoD under which it provides consultancy services but not products. In contrast BAe & Thales are prime contractors whose share prices are likely to swing with sentiment within the defence industry. The Cohort share price will not be subject to sentiment to the same extent and will increase as it continues to provide the primes with much needed support
Posted at 14/1/2025 07:30 by phg87
Happy with the results:

- Revenue, adjusted* operating profit and net funds all
ahead of recent guidance.
O Revenue up 25% to £118.2m (2023: £94.3m).
O Adjusted* operating profit up 69% to £10.1m
(2023: £6.0m). A net margin of 8.5% (2023: 6.4%).
O Adjusted* earnings per share of 20.00 pence
(2023: 10.36 pence) reflecting the marked
improvement in performance.
O Order intake of £139.2m (2023: £119.1m), 1.2x the
period’s revenue (2023: 1.3x).
O Record closing order book of £541.1m (30 April 2024: £518.7m).
O Interim dividend increased by over 10% to 5.25 pence
per share (2023: 4.70 pence per share) continuing the
Group’s long standing track record of progressive
dividend growth.
O Net funds of £37.9m at 31 October 2024 (31 October 2023:
£13.3m net funds; 30 April 2024: £23.1m net funds), well
ahead of expectations due to working
Posted at 13/12/2024 18:14 by xtrmntr
From the IC.There have been some recent jitters amongst defence stocks after US president-elect Donald Trump called for an "immediate ceasefire" in Ukraine. But the war has highlighted long-term underinvestment in defence and security in Europe, as has the incoming US administration's more antagonistic view of Nato. Aim-traded mini-defence conglomerate Cohort (CHRT) is navigating this demand context well, and is benefiting from heightened tensions in the Asia-Pacific and Middle East, evidenced by the company's disclosure of a record order book and revenue growth of a quarter in its first half. Sales to the UK Ministry of Defence (MOD), which contributed an increased 56 per cent of total revenue in the half, drove the revenue and profit performance. Both the communications and intelligence and sensors and effectors units delivered robust adjusted operating profit growth, as profit jumped 69 per cent to £10.1mn. The net margin improved from 6.4 per cent to 8.5 per cent, with progress being made towards management's medium-term mid-teen target. Encouragingly, management expects its Portuguese communications systems business EID, which has been loss-making over the past couple of years, to return to profit over the full year on the back of "long-awaited" naval orders. The order book sat at £541mn at the period-end, up from £519mn in April. and representing an order cover of 99 per cent of the analyst consensus for annual revenue. Order intake of £139mn was 1.2 times revenue in the half. Meanwhile, the £74mn acquisition of high-margin naval defence communications business EM Solutions (the transaction is expected to complete imminently) provides a tasty long-term opportunity. Clients include the Australian navy, Norwegian navy and Dutch defence department. The deal was part-funded through a £41mn share placing and retail offer. Chief executive Andy Thomas said the company was in discussions with more "big potential customers" for EM Solutions. Net funds improved by £15mn to £37.9mn, although a net cash outflow is anticipated in the second half, given capex, working capital movements and the EM Solutions purchase. Cohort trades on 20 times forward consensus earnings, a higher rating than at Chemring (CHG), as well as bigger sector beasts BAE Systems (BA.) and Lockheed Martin (US:LMT). The share price has more than doubled over the past year. But, as analysts at Shore Capital argued, Cohort is "visibly becoming a strategic supplier with clients, justifying a premium valuation", and there is an expectation of "strong news flow continuing for shareholders". We remain bullish on the outlook. Buy.
Posted at 12/12/2024 09:15 by estienne
Cohort own some very necessary military tools and I think the share price will double in the near term
Posted at 11/12/2024 07:30 by edmonda
Cohort (LON:CHRT) - H1'25 results: records continue to tumble - link to latest research:

For the six months to 31 October 2024 Cohort reported revenue (adj.) operating profit and net funds ahead of recent guidance: revenue +25%YoY at £118.2m, (adj.) EBIT +69%YoY to £10.1m and net funds at 31 October of £37.9m. Order intake of £139.2m compared to £119.1m a year earlier, with a record closing order book of £541.1m. EPS (adj., dil.) was 19.8p (H1 24: 10.3p) and the interim dividend was raised by 12%YoY to 5.25p/share.

Communications & Intelligence delivered revenue of £55.2m, +26%YoY and (adj.) EBIT of £8.5m, +41%YoY, a 15.4% margin compared to 13.7% a year earlier; the order book increased from £108.8m in April to £134.4m. Sensors & Effectors posted revenue of £64.2m, +26%YoY and (adj.) EBIT of £5.3m, +1.3x, an 8.3% margin compared to 4.5% in H1 24. Its closing order book was £406.8m (April, £410.7m) with H2 order intake expected to exceed revenue.

Post period-end, Cohort announced a conditional sale and purchase agreement to acquire Australian satellite communications specialist EM Solutions (Europe) B.V., for an enterprise value of c.£75.0m. The acquisition will take the Group pro forma order book to above £650m.

Recent events in Syria, the ongoing conflicts in Israel the Ukraine, and with persisting tension in the Far East / Asia Pacific region, serve as reminders of the importance to the UK of retaining an efficient and modernised defence capability.

We retain our Fair value / share of 1090p. That price is indicative of a FY26E PE of 19.0x compared to a peer group market cap weighted average of 22.2x, and EV/EBITDA of 10.1x, compared to 12.5x
Posted at 21/11/2024 08:36 by edmonda
a busy day at CHRT !

Positive H1 trading update, £40m placing to help buy EM Solutions for £75m - an Australian expert in SATCOM

EMS looks a great fit + expands Group's prouct offering. CHRT indeed sees deal as 'materially accretive' to adj EPS in year 1 of ownership.

Bravo
Posted at 16/11/2024 17:35 by tournesol
I sold CHRT at a substantial profit to avoid the potential risk of a change in the IHT treatment of AIM listed stocks which could have dragged on the share price

That risk seems to have receded.

I'm now minded to re-enter.
Posted at 26/9/2024 20:38 by wad collector
Robertball21 Jul '23 - 23:00 - 487 of 623
0 2 0
The share price will only change if there is a takeover bid or serious good news


Err , there are other possible reasons the share price may change. And given that the share price must have been about 450p then , are you saying that it has doubled because of the former or the latter?
Cohort share price data is direct from the London Stock Exchange

Cohort Frequently Asked Questions (FAQ)

What is the current Cohort share price?
The current share price of Cohort is 1,075.00p
How many Cohort shares are in issue?
Cohort has 46,571,003 shares in issue
What is the market cap of Cohort?
The market capitalisation of Cohort is GBP 530.91M
What is the 1 year trading range for Cohort share price?
Cohort has traded in the range of 520.00p to 1,240.00p during the past year
What is the PE ratio of Cohort?
The price to earnings ratio of Cohort is 32.08
What is the cash to sales ratio of Cohort?
The cash to sales ratio of Cohort is 2.43
What is the reporting currency for Cohort?
Cohort reports financial results in GBP
What is the latest annual turnover for Cohort?
The latest annual turnover of Cohort is GBP 202.53M
What is the latest annual profit for Cohort?
The latest annual profit of Cohort is GBP 15.32M
What is the registered address of Cohort?
The registered address for Cohort is 1 WATERSIDE DRIVE, ARLINGTON BUSINESS PARK, THEALE, READING, RG7 4SW
What is the Cohort website address?
The website address for Cohort is www.cohortplc.com
Which industry sector does Cohort operate in?
Cohort operates in the BUSINESS CONSULTING SVCS,NEC sector